Wed, April 3, 2024
Tue, April 2, 2024
Mon, April 1, 2024
Sun, March 31, 2024
Thu, March 28, 2024

Kristen Kluska Reiterated (ATNM) at Buy and Held Target at $21 on, Apr 1st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-21-on-apr-1st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Kristen Kluska of Cantor Fitzgerald, Reiterated "Actinium Pharmaceuticals, Inc." (ATNM) at Buy and Held Target at $21 on, Apr 1st, 2024.

Kristen has made no other calls on ATNM in the last 4 months.



There are 2 other peers that have a rating on ATNM. Out of the 2 peers that are also analyzing ATNM, 0 agree with Kristen's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Kristen


  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $30 on, Tuesday, March 19th, 2024
  • Yuan Zhi of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $16 on, Monday, December 11th, 2023

Publication Contributing Sources